Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Rhonda, Bohn"'
Autor:
Adam de Havenon, Charles E Leonard, Xi Tan, Aaron King, Neil Dhopeshwarkar, Rhonda Bohn, Katherine Dea
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 12, Iss 5 (2024)
Introduction This study aimed to assess recent trends in the US use of glucagon-like peptide-1 receptor agonist (GLP-1 RA) and sodium-glucose cotransporter 2 inhibitor (SGLT2i) in people with type 2 diabetes (T2D) and atherosclerotic cardiovascular d
Externí odkaz:
https://doaj.org/article/241fc9acf8aa4641a972e8d294236447
Autor:
Karin, Berger, Angelika, Batorova, Rhonda, Bohn, Matteo, di Minno, Pier Mannuccio, Mannucci, Kaan, Kavakli, Wolfgang, Schramm, Louis, Aledort
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 28(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f0e9f6ac44216bb7d4d16f2f830e5840
https://pubmed.ncbi.nlm.nih.gov/32398176
https://pubmed.ncbi.nlm.nih.gov/32398176
Autor:
Mufaddal Mahesri, Sebastian Schneeweiss, Denise Globe, Alex Mutebi, Rhonda Bohn, Maureen Achebe, Raisa Levin, Rishi J. Desai
Publikováno v:
European Journal of Haematology. 106:273-280
Objectives Bone marrow transplantation (BMT) is currently the only curative therapy available for patients with sickle cell disease (SCD), but clinical outcomes in routine care are not well understood. We describe the rates of vaso-occlusive crises (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba6b725b62e5656db150ef6f9409fca3
https://doi.org/10.1111/ejh.13546
https://doi.org/10.1111/ejh.13546
Autor:
Rishi J. Desai, Mufaddal Mahesri, Denise Globe, Alex Mutebi, Rhonda Bohn, Maureen Achebe, Raisa Levin, Sebastian Schneeweiss
Publikováno v:
Annals of hematology. 99(11)
To add to the limited existing evidence on clinical outcomes and healthcare use in sickle cell disease (SCD) among beneficiaries of the US Medicaid program, we conducted a cohort study using nationwide Medicaid claims data (2000–2013). Patients wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27d01d8604cede58360780b10fa32861
https://pubmed.ncbi.nlm.nih.gov/32869184
https://pubmed.ncbi.nlm.nih.gov/32869184
Publikováno v:
Clinical and experimental rheumatology. 36(2)
The incidence and prevalence of axial spondyloarthritis (axSpA), including ankylosing spondylitis (AS) and non-radiographic (nr-)axSpA, have been investigated in multiple populations, though there is a paucity of population-level data. Here, we ident
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b8166d40e9d588667a0dae9174d2911c
https://pubmed.ncbi.nlm.nih.gov/29148402
https://pubmed.ncbi.nlm.nih.gov/29148402
Autor:
Mufaddal Mahesri, Sebastian Schneeweiss, Raisa Levin, Denise Globe, Krista McKerracher, Alex Mutebi, Rhonda Bohn, Maureen Achebe, Rishi J Desai
Publikováno v:
Blood. 134:2166-2166
Introduction: Sickle cell disease (SCD) is a hereditary condition characterized by severe complications and repeated episodes of acute illness throughout life, leading to premature death. Blood and Marrow Transplantation (BMT) is the only available c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90389440f748f99a44e370fcc6846661
https://doi.org/10.1182/blood-2019-130724
https://doi.org/10.1182/blood-2019-130724
Autor:
Rishi J Desai, Mufaddal Mahesri, Raisa Levin, Denise Globe, Krista McKerracher, Alex Mutebi, Rhonda Bohn, Maureen Achebe, Sebastian Schneeweiss
Publikováno v:
Blood. 134:3459-3459
Introduction: There is limited contemporary evidence on clinical outcomes and healthcare use in sickle-cell disease (SCD) patients enrolled in US Medicaid. We aimed to provide contemporary estimates for rates of vaso-occlusive crises (VOC), mortality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84b40cdfbdba2f4800814a7317b4d620
https://doi.org/10.1182/blood-2019-130373
https://doi.org/10.1182/blood-2019-130373
Publikováno v:
The Journal of rheumatology. 30(4)
Nonselective nonsteroidal antiinflammatory drugs (NSAID) are well known to cause an increased risk of gastrointestinal (GI) hemorrhage, congestive heart failure, and hypertension, but the cost of such adverse effects has not been rigorously defined.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5228ebc3b1142e2558e8e77fd2d83de7
https://pubmed.ncbi.nlm.nih.gov/12672201
https://pubmed.ncbi.nlm.nih.gov/12672201